A detailed history of Bay Colony Advisory Group, Inc D transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 7,101 shares of BMY stock, worth $317,130. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,101
Previous 19,099 62.82%
Holding current value
$317,130
Previous $1.04 Million 71.59%
% of portfolio
0.05%
Previous 0.19%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$40.25 - $52.99 $482,919 - $635,774
-11,998 Reduced 62.82%
7,101 $294,000
Q1 2024

Apr 30, 2024

SELL
$47.98 - $54.4 $52,921 - $60,003
-1,103 Reduced 5.46%
19,099 $1.04 Million
Q4 2023

Jan 29, 2024

SELL
$48.48 - $57.85 $561,204 - $669,671
-11,576 Reduced 36.43%
20,202 $1.04 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $8,741 - $9,774
151 Added 0.48%
31,778 $1.84 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $25,611 - $28,437
402 Added 1.29%
31,627 $2.02 Million
Q1 2023

Apr 27, 2023

SELL
$65.71 - $74.53 $273,222 - $309,895
-4,158 Reduced 11.75%
31,225 $2.16 Million
Q4 2022

Feb 01, 2023

SELL
$68.48 - $81.09 $30,268 - $35,841
-442 Reduced 1.23%
35,383 $2.55 Million
Q3 2022

Oct 27, 2022

SELL
$0.13 - $76.84 $14 - $8,606
-112 Reduced 0.31%
35,825 $2.55 Million
Q2 2022

Aug 08, 2022

SELL
$72.62 - $79.98 $234,635 - $258,415
-3,231 Reduced 8.25%
35,937 $2.65 Million
Q1 2022

Apr 28, 2022

BUY
$61.48 - $73.72 $138,821 - $166,459
2,258 Added 6.12%
39,168 $2.86 Million
Q4 2021

Jan 28, 2022

BUY
$53.63 - $62.52 $108,171 - $126,102
2,017 Added 5.78%
36,910 $2.3 Million
Q3 2021

Nov 02, 2021

BUY
$59.17 - $69.31 $397,622 - $465,763
6,720 Added 23.85%
34,893 $2.07 Million
Q2 2021

Jul 22, 2021

BUY
$61.91 - $67.42 $31,016 - $33,777
501 Added 1.81%
28,173 $1.88 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $150,604 - $169,386
2,538 Added 10.1%
27,672 $1.75 Million
Q4 2020

Feb 02, 2021

BUY
$57.74 - $65.43 $32,565 - $36,902
564 Added 2.3%
25,134 $1.56 Million
Q3 2020

Nov 25, 2020

BUY
$57.43 - $63.64 $433,711 - $480,609
7,552 Added 44.38%
24,570 $1.48 Million
Q2 2020

Jul 23, 2020

SELL
$54.82 - $64.09 $39,251 - $45,888
-716 Reduced 4.04%
17,018 $1 Million
Q1 2020

Apr 17, 2020

BUY
$46.4 - $67.43 $61,387 - $89,209
1,323 Added 8.06%
17,734 $989,000
Q4 2019

Jan 28, 2020

SELL
$49.21 - $64.19 $591,012 - $770,921
-12,010 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$49.21 - $64.19 $807,585 - $1.05 Million
16,411 New
16,411 $1.11 Million
Q3 2019

Oct 25, 2019

BUY
$42.77 - $50.71 $322,656 - $382,556
7,544 Added 168.92%
12,010 $609,000
Q2 2019

Jul 17, 2019

BUY
$44.62 - $49.34 $199,272 - $220,352
4,466 New
4,466 $203,000
Q1 2019

Apr 30, 2019

SELL
$45.12 - $53.8 $198,437 - $236,612
-4,398 Closed
0 $0
Q4 2018

Jan 29, 2019

SELL
$48.76 - $63.23 $95,715 - $124,120
-1,963 Reduced 30.86%
4,398 $229,000
Q3 2018

Nov 05, 2018

BUY
$55.19 - $62.25 $12,748 - $14,379
231 Added 3.77%
6,361 $395,000
Q2 2018

Aug 09, 2018

BUY
$50.53 - $62.98 $309,748 - $386,067
6,130 New
6,130 $339,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $95B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.